Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 3 |  Issue 3

Table of Contents

Volume 3 |  Issue 3

Publication Date: December 2004
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
135		 Beyond PSA: A Need for Additional Markers for Prostate Cancer
Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
136-140		 Highlights from: the 29th European Society for Medical Oncology Congress; Vienna, Austria; October 29–November 2, 2004
Nancy Price, Tom Hutson, Oliver Sartor, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Research in Brief
Page Number of this Article in the Print Version
141-143		 Phase I/II Trial of Bortezomib plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
Nancy Price, Robert Dreicer, Tom Hutson, Vinay K. Jain, Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
144-149		 Early Use of Chemotherapy in Conjunction with Radical Prostatectomy
Joshi J. Alumkal, Michael A. Carducci
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
150-156		 Newer Therapies in Advanced Prostate Cancer
Robert B. Hegeman, Glenn Liu, George Wilding, Douglas G. McNeel
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
157-164		 Molecular Markers and Prostate Cancer Prognosis
Jonathan L. Chin, Robert E. Reiter
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
165-173		 Angiogenesis-Targeted Therapies in Prostate Cancer
Primo N. Lara, Jr, Przemyslaw Twardowski, David I. Quinn
  • Abstract
  • No Access
  • Add to Cart
Original Contribution
Page Number of this Article in the Print Version
174-181		 Preliminary Assessment of Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Outcome in Patients with Prostate Cancer at High Risk for Relapse
Darko Pucar, Jason A. Koutcher, Ankoor Shah, John P. Dyke, Lawrence Schwartz, Howard Thaler, John Kurhanewicz, Peter T. Scardino, W. Kevin Kelly, Hedvig Hricak, Kristen L. Zakian
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
182-183		 Role of Magnetic Resonance Spectroscopic Imaging in the Prediction of Treatment Outcome in Prostate Cancer
Tedros Bezabeh
  • Abstract
  • No Access
  • Add to Cart
Original Contribution
Page Number of this Article in the Print Version
184-188		 Measurement of Intracellular Versus Extracellular Prostate-Specific Antigen Levels in Peripheral Macrophages: A New Approach to Noninvasive Diagnosis of Prostate Cancer
Ralf Herwig, Alexandre Pelzer, Wolfgang Horninger, Peter Rehder, Helmut Klocker, Reinhold Ramoner, Germar M. Pinggera, Christian Gozzi, Guenther Konwalinka, Georg Bartsch
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
189-191		 Protease-Activated Receptor 1: A Role in Prostate Cancer Metastasis
Ta-Chun Yuan, Ming-Fong Lin
  • Abstract
  • No Access
  • Add to Cart